Best Biotech Stocks

Sage Therapeutics price target lowered to $15 from $26 at RBC Capital

RBC Capital lowered the firm’s price target on Sage Therapeutics (SAGE) to $15 from $26 and keeps a...

1d ago

Cantor Fitzgerald biopharma analyst holds analyst/industry conference call

SAGE

Biopharma Analyst Chen, along with Mitchell Epner, Senior Counsel Member of Kudman Trachten Aloe Posner, discuss the COVID...

1d ago

ABUS

MRNA

Biogen announces CHMP opinion recommending Tofidence

Biogen announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency,...

2d ago

Biogen receives positive CHMP opinion for TOFIDENCE

Biogen announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a...

2d ago

Gilead cuts FY24 adjusted EPS view to $3.45-$3.85 from $6.85-$7.25

Consensus $3.67. Sees FY24 product sales $27.1B-$27.5B. Published first on TheFly – the ultimate source for real-time, market-moving...

2d ago

Gilead reports Q1 adjusted EPS ($1.32), consensus ($1.39)

Reports Q1 revenue $6.7B, consensus $5.92B. “Gilead delivered another strong quarter of revenue growth in the first quarter...

2d ago

Gilead options imply 3.2% move in share price post-earnings

Pre-earnings options volume in Gilead is 8.0x normal with puts leading calls 5:3. Implied volatility suggests the market...

2d ago

Sage Therapeutics price target lowered to $18 from $22 at Truist

Truist lowered the firm’s price target on Sage Therapeutics (SAGE) to $18 from $22, while keeping a Hold...

2d ago

Notable companies reporting after market close

SAGE

Notable companies reporting after the market close, with earnings consensus, include Microsoft (MSFT), consensus $2.82… Alphabet (GOOGL), consensus...

2d ago

COF

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

Gilead Sciences

Hold

Reiterated

2024-04-26

REGN

Regeneron

Buy

Reiterated

2024-04-26

Biogen

Buy

Reiterated

2024-04-25

MRNA

Moderna

Hold

Reiterated

2024-04-24

VRTX

Vertex Pharmaceuticals

Sell

Reiterated

2024-04-23

BNTX

BioNTech SE

Hold

Reiterated

2024-04-23

AMGN

Amgen

Buy

Reiterated

2024-04-23

ILMN

Illumina

Hold

Reiterated

2024-04-22

IQV

IQVIA Holdings

Buy

Reiterated

2024-04-17

REGN

Regeneron

Buy

Assigned

2024-04-26

All Ratings >

Most Recent Earnings of Biotech Stocks

Gilead Sciences

Apr 25, 2024

Mar 01, 2024

-1.49 / -1.32

1.37

AMGN

Amgen

Feb 06, 2024

Dec 01, 2023

4.59 / 4.71

4.09

VRTX

Vertex Pharmaceuticals

Feb 05, 2024

Dec 01, 2023

4.07 / 4.20

3.76

Biogen

Apr 24, 2024

Mar 01, 2024

3.47 / 3.67

3.4

ILMN

Illumina

Feb 08, 2024

Dec 01, 2023

0.02 / 0.14

0.14

REGN

Regeneron

Feb 02, 2024

Dec 01, 2023

10.73 / 11.86

12.56

MRNA

Moderna

Feb 22, 2024

Dec 01, 2023

-0.99 / 0.55

3.61

IQV

IQVIA Holdings

Feb 14, 2024

Dec 01, 2023

2.82 / 2.84

2.78

BNTX

BioNTech SE

Mar 20, 2024

Dec 01, 2023

2.55 / 2.04

9.933

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

IQVIA Holdings - Strong Buy, based on 16 analyst ratings, 14 Buy, 2 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $65.42, and its average 12-month price target is $83.05.

Amgen's stock price is currently $269.98, and its average 12-month price target is $310.41.

Vertex Pharmaceuticals's stock price is currently $397.48, and its average 12-month price target is $456.11.

Biogen's stock price is currently $208.90, and its average 12-month price target is $284.96.

Illumina's stock price is currently $122.28, and its average 12-month price target is $151.18.

Regeneron's stock price is currently $883.20, and its average 12-month price target is $1,044.63.

Moderna's stock price is currently $107.97, and its average 12-month price target is $122.87.

IQVIA Holdings's stock price is currently $234.88, and its average 12-month price target is $278.69.

BioNTech SE's stock price is currently $87.21, and its average 12-month price target is $111.64.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.77 which represents an annual dividend yield of 4.50%. Gilead Sciences's next Ex-dividend date is June 14, 2024 and its next payout date is June 27, 2024.

Amgen currently pays a dividend of $2.25 which represents an annual dividend yield of 3.16%. Amgen's next Ex-dividend date is May 16, 2024 and its next payout date is June 7, 2024.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.

Latest News

Microsoft and Alphabet: Top Analysts Choose the Best AI Stocks to Buy After Earnings

MSFT

AbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition

ABBV

Biden Administration Pauses Planned Ban of Menthol Cigarettes

BTI

Stock Market News Today, 04/26/24 – Indices Rise; Inflation Data Heats Up

NDX

SPX

Is Bob Bakish on Borrowed Time at Paramount (NASDAQ:PARA)?

APO

PARA

Can Broadcom Stock (NASDAQ:AVGO) Join the $1 Trillion Club?

AMD

AVGO

Chicken Supply Normalizes at Chipotle (NASDAQ:CMG), Shares Spark Up

CMG

Roku (NASDAQ:ROKU) Craters amid Rising FAST Competiton

ROKU

More Plane Trouble for Boeing (NYSE:BA)

DAL

Royal Caribbean Cruises (NYSE:RCL): Record Sales and Record Risk

RCL

Petrobras (NYSE:PBR) Settles Dividend Struggle, Shares Surge

PBR

Pfizer (NYSE:PFE) Notches Up on New FDA Approval

PFE

IMO Earnings: Imperial Oil Slips despite Decent Earnings

IMO

Earning Big in the Gaming World: Immutable Launches a Multi-Million Dollar Quest

BITCOIN